Frontiers in Immunology | Cancer Immunity and Immunotherapy

Editorial

Published on 04 Apr 2023

Editorial: The immune escape mechanism and novel immunotherapeutic strategies of leukemia

in Cancer Immunity and Immunotherapy

Kang Yu
Jialing Zhang
Qianping Li
Shenghui Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1188582

1,492 views
1 citation

Mini Review

Published on 04 Apr 2023

Immune-related pulmonary toxicities of checkpoint inhibitors in non-small cell lung cancer: Diagnosis, mechanism, and treatment strategies

in Cancer Immunity and Immunotherapy

Xinyu Guo
Shi Chen
Xueyan Wang
Xiaowei Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1138483

14,033 views
21 citations

Original Research

Published on 04 Apr 2023

Antitumor activity and safety of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma: An open-label, multicenter, phase II study

in Cancer Immunity and Immunotherapy

Yanfei Liu
Yuqin Song
Shubo Zuo
Xian Zhang
Hui Liu
Jingwen Wang
Jingbo Wang
Yongjing Tang
Wen Zheng
Zhitao Ying

Frontiers in Immunology

doi 10.3389/fimmu.2023.1128172

2,993 views
5 citations

Review

Published on 04 Apr 2023

NLRP3 inflammasome-induced pyroptosis in digestive system tumors

in Cancer Immunity and Immunotherapy

Jiexia Wen
Bin Xuan
Yang Liu
Liwei Wang
Li He
Xiangcai Meng
Tao Zhou
Yimin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1074606

10,141 views
26 citations

Original Research

Published on 04 Apr 2023

Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma

in Cancer Immunity and Immunotherapy

Ji Chen
Mengjiao Sun
Chuqin Chen
Meiyun Kang
Bo Qian
Jing Sun
Xiaopeng Ma
Jianfeng Zhou
Lei Huang
Bin Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1135617

3,394 views
3 citations

Original Research

Published on 04 Apr 2023

Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma

in Cancer Immunity and Immunotherapy

Xinnian Yu
Linjun Xie
Jianjuan Ge
Huixin Li
Shanliang Zhong
Xiaolin Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1145300

32,524 views
49 citations

Original Research

Published on 04 Apr 2023

Generation of a symmetrical trispecific NK cell engager based on a two-in-one antibody

in Cancer Immunity and Immunotherapy

Julia Harwardt
Stefania C. Carrara
Jan P. Bogen
Katrin Schoenfeld
Julius Grzeschik
Björn Hock
Harald Kolmar

Frontiers in Immunology

doi 10.3389/fimmu.2023.1170042

11,619 views
8 citations

Original Research

Published on 04 Apr 2023

Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Wuguang Chang
Hongmu Li
Yixin Cheng
Huanhuan He
Wei Ou
Si-Yu Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1171145

3,823 views

Review

Published on 04 Apr 2023

Opportunities and challenges to engineer 3D models of tumor-adaptive immune interactions

in Cancer Immunity and Immunotherapy

Rahul M. Visalakshan
Mary K. Lowrey
Mauricio G. C. Sousa
Haylie R. Helms
Abrar Samiea
Carolyn E. Schutt
Josh M. Moreau
Luiz E. Bertassoni

Frontiers in Immunology

doi 10.3389/fimmu.2023.1162905

7,938 views
11 citations

Hypothesis and Theory

Published on 03 Apr 2023

Epigenetic control of CD1D expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomas

in Cancer Immunity and Immunotherapy

Mona Meng Wang
Saara A. Koskela
Arfa Mehmood
Miriam Langguth
Eleftheria Maranou
Carlos R. Figueiredo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1152228

4,991 views
8 citations

Original Research

Published on 03 Apr 2023

Human lymphocytes mobilized with exercise have an anti-tumor transcriptomic profile and exert enhanced graft-versus-leukemia effects in xenogeneic mice

in Cancer Immunity and Immunotherapy

Helena Batatinha
Douglass M. Diak
Grace M. Niemiro
Forrest L. Baker
Kyle A. Smith
Tiffany M. Zúñiga
Preteesh L. Mylabathula
Michael D. Seckeler
Branden Lau
Emily C. LaVoy

Frontiers in Immunology

doi 10.3389/fimmu.2023.1067369

7,743 views
14 citations

Original Research

Published on 03 Apr 2023

Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Qin Yang
Weiyuan Zhu
Han Gong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1148483

4,212 views
10 citations

Original Research

Published on 03 Apr 2023

Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Ruonan Sun
Jiawei Li
Xianyi Lin
Yidong Yang
Bing Liu
Tianbi Lan
Shuang Xiao
Anyi Deng
Zhinan Yin
Yan Xu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1079495

6,911 views
15 citations

Original Research

Published on 03 Apr 2023

Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC

in Cancer Immunity and Immunotherapy

Jihang Shi
Guangya Li
Lulu Liu
Xiandun Yuan
Yafei Wang
Ming Gong
Chonghui Li
Xinlan Ge
Shichun Lu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1166052

8,995 views
11 citations

Correction

Published on 31 Mar 2023

Corrigendum: Single-cell RNA-seq analysis reveals cellular functional heterogeneity in dermis between fibrotic and regenerative wound healing fates

in Cancer Immunity and Immunotherapy

Cao-Jie Chen
Hiroki Kajita
Kento Takaya
Noriko Aramaki-Hattori
Shigeki Sakai
Toru Asou
Kazuo Kishi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1175360

2,264 views

Systematic Review

Published on 31 Mar 2023

Biomarkers predicting clinical outcomes in nasopharyngeal cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Xiaoyan Qian
Haizhu Chen
Yunxia Tao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1146898

5,432 views
10 citations